NHLD - National Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.8000
-0.0400 (-1.41%)
At close: 3:27PM EST
Stock chart is not supported by your current browser
Previous Close2.8400
Open2.7898
Bid2.8000 x 1000
Ask2.8100 x 2200
Day's Range2.7800 - 2.8300
52 Week Range2.1700 - 3.7000
Volume20,719
Avg. Volume6,054
Market Cap37.177M
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-0.0640
Earnings DateFeb 12, 2020 - Feb 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateApr 30, 1996
1y Target EstN/A
  • GlobeNewswire

    National Holdings Corporation Announces Closing of Acquisition of Full-Service Investment Firm Winslow, Evans & Crocker, Inc.

    As a result of this acquisition, National now has 717 registered representatives, and manages in excess of $15 billion of Assets Under Management. Winslow, Evans & Crocker, Inc. (Winslow), is a Boston-based, full-service investment firm established in 1991.

  • GlobeNewswire

    National Holdings Corporation Reports Financial Results for the 2019 Fiscal Fourth Quarter and 2019 Fiscal Year

    NEW YORK, Dec. 31, 2019 -- National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading.

  • Healthcare Trust Announces Close of the Full Exercise of Underwriters' Option for its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock Offering
    PR Newswire

    Healthcare Trust Announces Close of the Full Exercise of Underwriters' Option for its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock Offering

    Healthcare Trust, Inc. ("HTI" or the "Company") today announced that the underwriters have purchased an additional 210,000 shares of the Company's 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock with a liquidation preference of $25.00 (the "Series A Preferred Stock"), pursuant to the full exercise of the underwriters' option to purchase additional shares in the offering that initially closed on December 11, 2019. The Series A Preferred Stock is listed on The Nasdaq Global Market under the symbol "HTIA."

  • Healthcare Trust Prices Public Offering of 1,400,000 Shares of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
    PR Newswire

    Healthcare Trust Prices Public Offering of 1,400,000 Shares of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock

    Healthcare Trust, Inc. ("HTI" or the "Company") today announced the pricing of an underwritten public offering of 1,400,000 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") at a public offering price of $25.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 210,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have been approved for listing and are expected to begin trading on The Nasdaq Global Market on December 11, 2019 under the symbol "HTIA." The Series A Preferred Stock will have a $25.00 liquidation preference per share.

  • PR Newswire

    WhiteHorse Finance, Inc. Announces Pricing of Public Offering by Selling Stockholders

    WhiteHorse Finance, Inc., a business development company (the "Company") (Nasdaq: WHF), today announced that certain of its stockholders (the "Selling Stockholders"), which are funds affiliated with H.I.G. Capital, LLC ("H.I.G. Capital"), have priced an underwritten, public offering of 2,250,000 shares of common stock of the Company at a public offering price of $13.83 per share pursuant to the Company's shelf registration statement, which was filed with, and has been declared effective by, the Securities and Exchange Commission (the "Commission").

  • Healthcare Trust Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock
    PR Newswire

    Healthcare Trust Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock

    Healthcare Trust, Inc. ("HTI" or the "Company") today announced the launch of a proposed underwritten public offering of 1,400,000 shares of its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock"), pursuant to a registration statement on Form S-11 filed with the Securities and Exchange Commission (the "Commission"). The underwriters are expected to be granted a 30-day option to purchase up to an additional 210,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have been approved for listing on The Nasdaq Global Market.

  • PR Newswire

    WhiteHorse Finance, Inc. Announces Public Offering by Selling Stockholders

    WhiteHorse Finance, Inc., a business development company (the "Company") (Nasdaq:WHF), today announced that certain of its stockholders (the "Selling Stockholders"), which are funds affiliated with H.I.G. Capital, LLC ("H.I.G. Capital"), plan to make a secondary public offering of shares of common stock of the Company.

  • Global Net Lease Prices Public Offering of 3,000,000 Shares of 6.875% Series B Cumulative Redeemable Perpetual Preferred Stock
    PR Newswire

    Global Net Lease Prices Public Offering of 3,000,000 Shares of 6.875% Series B Cumulative Redeemable Perpetual Preferred Stock

    In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of Series B Preferred Stock. The Company has applied to list the shares of Series B Preferred Stock on the New York Stock Exchange.

  • GlobeNewswire

    Checkpoint Therapeutics Announces Pricing of Public Offering of Common Stock

    Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the pricing of its previously announced underwritten public offering. Checkpoint is offering 13,400,000 shares of its common stock, par value $0.0001 per share, at a price to the public of $1.27 per share. In connection with the offering, Checkpoint has also granted the underwriters a 45-day option to purchase up to an additional 2,010,000 shares of common stock offered in the public offering, at the same public offering price per share, less underwriting discounts and commissions.

  • GlobeNewswire

    Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock

    Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Checkpoint expects to grant the underwriters a 45‐day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering. All of the shares of common stock are being offered by Checkpoint.

  • TFF Pharmaceuticals goes public, raises $22M
    American City Business Journals

    TFF Pharmaceuticals goes public, raises $22M

    TFF is an early-stage biopharmaceutical company developing a range of drugs, including to treat serious lung conditions. TFF stands for thin film freezing, which is the company's patented process to make drugs that can be taken with an inhaler. That can significantly impact the effectiveness of drugs — for example, by specifically targeting the lungs and boosting absorption.

  • GlobeNewswire

    Fidus Investment Corporation Announces Exercise and Closing of Underwriters’ Overallotment Option to Purchase Additional 5.375% Notes Due 2024

    Fidus Investment Corporation (FDUS) (“Fidus” or the “Company”) today announced that, in connection with its previously disclosed registered public offering of $55.0 million aggregate principal amount of its 5.375% notes due 2024 (the “Existing Notes”) that closed on October 16, 2019, the underwriters of such offering have exercised their overallotment option in full to purchase an additional $8.3 million aggregate principal amount of its 5.375% notes due 2024 (the “Additional Notes” and together with the Existing Notes, the “Notes”). The total net proceeds to the Company from the offering of the Notes is approximately $61.0 million based on a public offering price of 100% of the aggregate principal amount of the Notes, after deducting payment of underwriting discounts and commissions and estimated offering expenses payable by the Company.

  • GlobeNewswire

    Fidus Investment Corporation Announces Closing of Public Offering of $55,000,000 5.375% Notes Due 2024

    Fidus Investment Corporation (FDUS) (“Fidus” or the “Company”) today announced that it has closed a registered public offering of $55.0 million aggregate principal amount of its 5.375% notes due 2024 (the “Notes”), which resulted in net proceeds to the Company of approximately $53.0 million based on a public offering price of 100% of the aggregate principal amount of the Notes, after deducting payment of underwriting discounts and commissions and estimated offering expenses payable by the Company. The Notes are expected to be listed, and trade, on The Nasdaq Global Select Market under the trading symbol “FDUSG” within 30 days of October 16, 2019.

  • Thomson Reuters StreetEvents

    Edited Transcript of NHLD earnings conference call or presentation 15-Aug-19 12:30pm GMT

    Q3 2019 National Holdings Corp Earnings Call

  • GlobeNewswire

    National Holdings Corporation to Acquire Full-Service Investment Firm Winslow, Evans & Crocker, Inc.

    National Holdings Corporation (NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking and asset management firm providing a wide array of services, today announced that it has entered into a definitive purchase agreement to acquire Winslow, Evans & Crocker, Inc., an employee-owned full-service investment firm. Winslow, Evans & Crocker, Inc. (Winslow), is a Boston-based, full-service investment firm established in 1991. Winslow is an SEC Registered Investment Advisor and a FINRA registered broker-dealer.

  • GlobeNewswire

    National Holdings Corporation Adds Strategic New Hires to its Broker Dealer Subsidiary

    NEW YORK, Aug. 19, 2019 -- National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a full-service independent brokerage, investment banking, insurance,.

  • GlobeNewswire

    National Holdings Corporation Reports Financial Results for the Fiscal 2019 Third Quarter

    NEW YORK, Aug. 15, 2019 -- National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading.

  • GlobeNewswire

    National Holdings Corporation (Nasdaq: NHLD) to Ring The Nasdaq Stock Market Closing Bell

    NEW YORK, Aug. 08, 2019 -- What: National Holdings Corporation (Nasdaq: NHLD), a full-service investment banking and asset management firm, will visit the Nasdaq MarketSite.

  • GlobeNewswire

    AzurRx BioPharma Announces Proposed Public Offering of Common Stock

    H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.  National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NHLD), is acting as a co-manager for the offering.

  • GlobeNewswire

    Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners

    Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business of Cancer Genetics, Inc. (CGIX) (the “BioPharma Business”) for approximately $23.5 million subject to certain adjustments. The acquisition is expected to create a leading oncology testing and service company in the clinical diagnostic and Biopharma markets, leveraging sophisticated assays, novel algorithms and custom service capabilities across the continuum of oncology from precancerous assessment to drug discovery and clinical trial support. In conjunction with this acquisition Ampersand Capital Partners, one of the leading private equity firms in the diagnostic/biopharma sector, agreed to invest $27M in Interpace in two tranches of newly issued convertible preferred stock, a portion of which will be subject to approval by Interpace’s shareholders.

  • GlobeNewswire

    Gladstone Land Corporation Announces Pricing of Common Stock Offering

    Gladstone Land Corporation (LAND) (the “Company”) today announced that it has priced its public offering of 2,000,000 shares of its common stock at a price to the public of $11.73 per share. The Company also granted the underwriters a 30-day option to purchase up to 300,000 additional shares of common stock solely to cover over-allotments, if any. The net proceeds to the Company, after deducting the underwriting discount and estimated offering expenses, are expected to be approximately $22.3 million (exclusive of the underwriters’ over-allotment option).

  • GlobeNewswire

    Mohawk Group Holdings, Inc. Closes Its Initial Public Offering

    NEW YORK, June 14, 2019 -- Mohawk Group Holdings, Inc. (NasdaqCM:MWK) (“Mohawk”) today announced the closing of its initial public offering of 3,600,000 shares of its common.

  • GlobeNewswire

    Mohawk Group Holdings, Inc. Announces Pricing of Initial Public Offering

    NEW YORK, June 12, 2019 -- Mohawk Group Holdings, Inc. (“Mohawk”) today announced the pricing of its initial public offering of 3,600,000 shares of its common stock, at a.

  • Thomson Reuters StreetEvents

    Edited Transcript of NHLD earnings conference call or presentation 16-May-19 12:30pm GMT

    Q2 2019 National Holdings Corp Earnings Call

  • GlobeNewswire

    Atomera Announces $6.7 Million Registered Direct Offering of Common Stock

    Atomera Incorporated (ATOM) today announced that it has entered into a definitive stock purchase agreement with institutional investors for the purchase of 1,675,000 shares of common stock, at an offering price of $4.00 per share, in a registered direct offering, for expected gross proceeds of approximately $6.7 million before placement agent fees and other offering expenses payable by Atomera. National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NHLD), is acting as sole placement agent for the offering.  The Liquid Venture Partners group at National Securities Corporation was responsible for sourcing and executing the offering.